Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2

AIMS: Concern has been raised that treatment with angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers may increase the expression of angiotensin‐converting enzyme 2 (ACE2), which acts as the entry receptor for SARS‐CoV‐2, and lead to an increased risk of death from SARS‐CoV‐2....

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Tobias, Walter, Joan Elias, Lopez‐Ayala, Pedro, Strebel, Ivo, Amrein, Melissa, Koechlin, Michael, Honegger, Ursina, Mueller, Christian, Albus, Miriam, Zellweger, Michael, Liu, Yu‐Ching, Glarner, Noemi, Boeddinghaus, Jasper, Freese, Michael, Haaf, Philip, Gualandro, Danielle M., Prepoudis, Alexandra, Leu, Kathrin, Schaerli, Nicolas, Belkin, Maria, Wildi, Karin, Puelacher, Christian, Shrestha, Samyut, Wussler, Desiree, Diebold, Matthias, Rentsch, Katharina, Buser, Andreas, du Fay de Lavallaz, Jeanne, Koechlin, Luca, Twerenbold, Raphael, Nestelberger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006721/
https://www.ncbi.nlm.nih.gov/pubmed/34596976
http://dx.doi.org/10.1002/ehf2.13249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006721/
https://www.ncbi.nlm.nih.gov/pubmed/34596976
http://dx.doi.org/10.1002/ehf2.13249

Ejemplares similares